Xeltis xeltis.com


Public lists: Pharma Startups (4729)

Xeltis is developing synthetic biodegradable heart valves and blood vessels ("matrices"), enabling a completely new therapeutic category called Endogenous Tissue Growth ("ETG"). Xeltis' proprietary technology, based on Nobel prize-winning science, is designed to stimulate and guide the body's natural healing response from the inside, leading to spontaneous growth of new valves and vessels within the body, once the matrices are implanted. The matrices are intended to biodegrade as natural tissue ...Show all

Xeltis is developing synthetic biodegradable heart valves and blood vessels ("matrices"), enabling a completely new therapeutic category called Endogenous Tissue Growth ("ETG"). Xeltis' proprietary technology, based on Nobel prize-winning science, is...Show all

Company (Alive / Active)

Phone: +41 44 269 79 79

Fax:

Mühlebachstrasse 26

Zurich, CH-8008
Switzerland

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Xeltis $90.5M Nov 15, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Xeltis Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Life Sciences PartnersVenture CapitalAmsterdam, NetherlandsSeries B - II, Series B
VI PartnersVenture CapitalSwitzerlandSeries C, Series B - II, Series B
Ysios Capital PartnersVenture CapitalBarcelona, SpainSeries C
Kurma PartnersVenture CapitalParis, FranceSeries C, Series B - II, Series B
See all 4 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Implant Jul 05, 2013 Jan 30, 2018 Patent
Use of a fluorinated polymer as a contrast agent in solid state 19f magnetic resonance imaging (mri), scaffold comprising said polymer and use thereof Dec 02, 2011 Dec 29, 2015 Patent
In situ tissue engineering Jun 16, 2015 Application
Methods and compositions for blood vessel tissue repair and engineering Jun 02, 2014 Application